636. Myelodysplastic Syndromes: Basic and Translational: Poster II

Interim Results of the CMML scrna seq atlas GMP skewing is independently associated with overall survival in CMML

Synergistic apoptotic effect by the combination of clk inhibitor CTX 712 and BCL 2 inhibitor ABT 199 with or without azacytidine in AML and MDS

Treatment with luspatersept exerts a pleiotropic effect on the molecular signatures of bone marrow cell subsets

Functional classification of monoallelic TP53 mutations refines prognostic stratification in myelodysplastic neoplasms

Integrated analysis of autoantibody profiles and clonal distribution of RAS mutations in juvenile myelomonocytic leukemia

Immunosuppressive T cell landscape in myelodysplastic Neoplasms with TP53 mutations

Spatial multiomics reveal a critical role for TIM4 expressing macrophages in blast transformation of chronic myelomonocytic leukemia

Single cell multi omics profiling reveals distinct patterns of clonal expansion and microenvironmental shifts associated with disease evolution in patients with Myelodysplastic Syndromes

Examining the role of U2AF1 and TET2 mutations in a myeloid malignancy mouse model

Novel approaches to identify cellular vulnerabilities in TET2 dependent MDS